Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|15|13|1110-1121

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.15, Iss.13, 2015-09, pp. : 1110-1121

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small-molecule inhibitors/modulators of amyloid-β peptide aggregation and toxicity for the treatment of Alzheimer's disease: a patent review (2010 – 2012)

By Belluti Federica   Rampa Angela   Gobbi Silvia   Bisi Alessandra  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 581-596

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Amyloid-&bgr; Aggregation in Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 20, Iss. 8, 2014-03 ,pp. : 1223-1243

Bentham Science Publishers

Access to resources Recommend Favorite

Disrupting &bgr;-Amyloid Aggregation for Alzheimer Disease Treatment

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 1, 2007-01 ,pp. : 115-126

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of HMG-CoA Reductase Inhibitors on β-Amyloid Peptide Levels: Implications for Alzheimer's Disease

By Höglund Kina   Blennow Kaj  

CNS Drugs, Vol. 21, Iss. 6, 2007-01 ,pp. : 449-462

Adis International

Access to resources Recommend Favorite

beta-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer Disease Dream or Reality?

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-07 ,pp. : 175-186

Bentham Science Publishers

Access to resources Recommend Favorite